Novel rhoptry effector proteins in Toxoplasma host-pathogen interaction

弓形虫宿主-病原体相互作用中的新型棒状体效应蛋白

基本信息

项目摘要

DESCRIPTION (provided by applicant): Toxoplasma gondii is an obligate intracellular parasite that causes severe central nervous system disorders in immunocompromised individuals and birth defects in congenitally infected neonates. Intracellular survival of these organisms is dependent on the ability to invade their host cell, establish a replication-permissive niche, and avoid host cell defenses. The secretory rhoptries have emerged as a key organelle that regulates both invasion and hijacking of host cell functions. For hijacking host functions, the rhoptries inject a burst of proteins into the host cell cytoplasm that can be trafficked to distinct compartments within the infected cell and directly target host pathways. The importance of these host "effector" proteins is exemplified by a family of rhoptry kinases that are injected and play critical roles in modulating host signaling pathways and regulating parasite virulence. In addition to ROP kinases, the rhoptries inject an array of other effector proteins that are of unknown function. Most of these proteins lack homology to known proteins or identifiable domains and are unique to Toxoplasma and closely related parasites. We have identified a panel of these novel rhoptry effectors and developed gene knockouts in the biologically relevant type II strain parasites for their study. In this proposal, we will determine the role of these novel effector proteins in regulating host functions. Specifically, we will determine the host response to ?effector strains in vitro using host microarray analysis and in vivo by assessing virulence, tissue tropism, and bradyzoite formation in mice. We will additionally use exogenous expression of tandem affinity tagged effector proteins in host cells to determine their destination and identify host targets. Together, these complementary approaches promise to reveal novel mechanistic insights into how Toxoplasma uses this unique set of effector proteins to modulate its mammalian host cell. PUBLIC HEALTH RELEVANCE: Toxoplasma gondii is an intracellular parasite that infects up to a third of the world's human population and causes serious disease in immunocompromised (AIDS) patients and congenitally-infected neonates. Toxoplasma secretes an array of factors from an organelle named the rhoptries that enable it to invade and hijack its host cell. This project is focused determining the function of a novel group of rhoptry effector proteins by examining the host response to gene knockout parasites and identifying host proteins that interact with these novel effectors.
描述(申请人提供):弓形虫是一种专性细胞内寄生虫,可在免疫功能受损的个体中引起严重的中枢神经系统疾病,并在先天性感染的新生儿中引起出生缺陷。这些生物的细胞内生存取决于入侵它们的宿主细胞、建立允许复制的生态位和避免宿主细胞防御的能力。分泌杆状病毒已成为调节宿主细胞入侵和劫持功能的关键细胞器。为了劫持宿主功能,棒状病毒向宿主细胞细胞质注入一系列蛋白质,这些蛋白质可以被运输到受感染细胞内的不同隔室,并直接针对宿主途径。这些宿主“效应器”蛋白的重要性被注射的一系列棒状蛋白所证明,这些蛋白在调节宿主信号通路和调节寄生虫毒力方面发挥关键作用。除了ROP激酶,棒状病毒还会注入一系列其他功能未知的效应器蛋白。这些蛋白大多缺乏与已知蛋白或可识别结构域的同源性,是弓形虫和密切相关寄生虫所特有的。我们已经确定了一组新的棒状病毒效应器,并在生物学上相关的II型寄生虫中开发了基因敲除,用于他们的研究。在这项提案中,我们将确定这些新的效应蛋白在调节宿主功能中的作用。具体地说,我们将在体外使用宿主微阵列分析来确定宿主对效应菌株的反应,并在体内通过评估小鼠的毒力、组织嗜性和缓殖体形成来确定宿主的反应。此外,我们还将在宿主细胞中使用串联亲和标记效应器蛋白的外源表达来确定它们的目的地和识别宿主靶标。总之,这些互补的方法有望揭示弓形虫如何利用这组独特的效应蛋白来调节其哺乳动物宿主细胞的新的机制洞察力。 与公共卫生相关:弓形虫是一种细胞内寄生虫,感染多达三分之一的世界人口,并在免疫功能低下(艾滋病)患者和先天性感染的新生儿中导致严重疾病。弓形虫分泌一系列来自细胞器的因子,这种细胞器被称为棒状病毒,使其能够入侵和劫持宿主细胞。该项目的重点是通过检测宿主对基因敲除寄生虫的反应来确定一组新的杆状病毒效应器蛋白的功能,并确定与这些新效应器相互作用的宿主蛋白。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter John Bradley其他文献

Peter John Bradley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter John Bradley', 18)}}的其他基金

Functional Analysis of Novel Components of the Toxoplasma Inner Membrane Complex
弓形虫内膜复合物新成分的功能分析
  • 批准号:
    9533992
  • 财政年份:
    2017
  • 资助金额:
    $ 23.1万
  • 项目类别:
Functional Analysis of Novel Components of the Toxoplasma Inner Membrane Complex
弓形虫内膜复合物新成分的功能分析
  • 批准号:
    10444432
  • 财政年份:
    2017
  • 资助金额:
    $ 23.1万
  • 项目类别:
Functional Analysis of Novel Components of the Toxoplasma Inner Membrane Complex
弓形虫内膜复合物新成分的功能分析
  • 批准号:
    9384311
  • 财政年份:
    2017
  • 资助金额:
    $ 23.1万
  • 项目类别:
Functional Analysis of Novel Components of the Toxoplasma Inner Membrane Complex
弓形虫内膜复合物新成分的功能分析
  • 批准号:
    10550156
  • 财政年份:
    2017
  • 资助金额:
    $ 23.1万
  • 项目类别:
Novel Dense Granule Protein Function in the Chronic Toxoplasma Infection
慢性弓形虫感染中的新型致密颗粒蛋白功能
  • 批准号:
    9221240
  • 财政年份:
    2016
  • 资助金额:
    $ 23.1万
  • 项目类别:
Novel Dense Granule Protein Function in the Chronic Toxoplasma Infection
慢性弓形虫感染中的新型致密颗粒蛋白功能
  • 批准号:
    9141001
  • 财政年份:
    2016
  • 资助金额:
    $ 23.1万
  • 项目类别:
Reconstitution of Plasmodium Export in Toxoplasma
弓形虫中疟原虫输出的重建
  • 批准号:
    8463994
  • 财政年份:
    2012
  • 资助金额:
    $ 23.1万
  • 项目类别:
Reconstitution of Plasmodium Export in Toxoplasma
弓形虫中疟原虫输出的重建
  • 批准号:
    8356983
  • 财政年份:
    2012
  • 资助金额:
    $ 23.1万
  • 项目类别:
Novel rhoptry effector proteins in Toxoplasma host-pathogen interaction
弓形虫宿主-病原体相互作用中的新型棒状体效应蛋白
  • 批准号:
    8416941
  • 财政年份:
    2012
  • 资助金额:
    $ 23.1万
  • 项目类别:
The Role of Toxoplasma Rhoptries in Host Cell Infection
弓形虫在宿主细胞感染中的作用
  • 批准号:
    7153481
  • 财政年份:
    2005
  • 资助金额:
    $ 23.1万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 23.1万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了